Chrysantis' EZ Eyes accepted as NDI
Chrysantis is ready to start selling EZ Eyes to dietary supplement makers following the FDA's acceptance of the marigold-derived natural zeaxanthin as a new dietary ingredient (NDI), reports Jess Halliday.
News, Analysis & Insights on Nutrition, Supplements, and Health
Chrysantis is ready to start selling EZ Eyes to dietary supplement makers following the FDA's acceptance of the marigold-derived natural zeaxanthin as a new dietary ingredient (NDI), reports Jess Halliday.
US scientists will investigate whether ginger can help cancer patients avoid nausea and vomiting from chemotherapy.
A mixture of peptides derived from colostrum could help slow the progression of Alzheimer's disease by reducing the build-up of beta amyloid, a toxic protein that accumulates in the brains of Alzheimer's sufferers, reports Dominique Patton.
A new study into the ability of mistletoe to decrease the reoccurrence of tumors in bladder cancer patients seems to show that it is as effective as the most common conventional approach, but without the side effects. But scientific opinion is divided...
UK scientists have identified previously unknown compounds in the potato that are also found in a herbal used to lower blood pressure, reports Dominique Patton.
The latest LOHAS consumer trends study suggests that a healthy spin may no longer be enough to lure people to new food and beverage products. Marketers may need to take another look at strategies for capturing the attention of this important group,...
Sabinsa Corporation has lowered the heavy metal limits for Selenium SeLECT in the face of tightening regulations in the European Union and interest from research institutes who wish to use it in studies, reports Jess Halliday.